Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Catherine Belle Meador, M.D.

Concepts (115)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms172024130961.160 Why?
Drug Resistance, Neoplasm9202051690.820 Why?
Thoracic Neoplasms120232680.740 Why?
Carcinoma, Non-Small-Cell Lung5202352210.720 Why?
Leadership2201613570.570 Why?
Small Cell Lung Carcinoma420233880.560 Why?
Protein Kinase Inhibitors6202155290.520 Why?
Molecular Targeted Therapy3202027270.510 Why?
Genotype32021129560.510 Why?
Antineoplastic Agents62021136680.460 Why?
Biomedical Research2201633110.370 Why?
Mutation112023297840.330 Why?
MAP Kinase Signaling System2201515250.330 Why?
Proto-Oncogene Proteins B-raf2201520410.310 Why?
Acrylamides320172550.260 Why?
Negotiating220161330.250 Why?
Neoplasms42023216720.250 Why?
Education, Medical, Graduate1201622910.240 Why?
Education, Medical1201617210.230 Why?
Aniline Compounds320179860.210 Why?
Career Choice220167440.180 Why?
Tumor Microenvironment3202435840.170 Why?
Paraneoplastic Syndromes, Nervous System12019230.170 Why?
Biology120212940.170 Why?
Genetic Variation1201465460.160 Why?
Quinazolines2201513560.160 Why?
Cardiology Service, Hospital120192460.150 Why?
Mice, Nude4201736890.140 Why?
Focal Adhesion Protein-Tyrosine Kinases120171820.140 Why?
Receptor, EphA212016420.140 Why?
Exons1202124390.130 Why?
Colorectal Neoplasms1201567730.130 Why?
Group Processes120162250.120 Why?
src-Family Kinases120175510.120 Why?
Niacinamide120164160.120 Why?
Lymphocytes, Tumor-Infiltrating1201910390.110 Why?
Humans2320247442200.110 Why?
Curriculum2201636040.110 Why?
Professional Competence120164480.110 Why?
INDEL Mutation120132790.100 Why?
Patient Admission1201913800.100 Why?
Cell Line, Tumor62023166870.100 Why?
Cell Lineage1202025040.100 Why?
Benzamides1201613780.090 Why?
DNA, Neoplasm1201517580.090 Why?
Academic Medical Centers1201927590.080 Why?
Antineoplastic Combined Chemotherapy Protocols32017114930.070 Why?
Piperazines1201724910.070 Why?
Receptor Protein-Tyrosine Kinases1201416600.070 Why?
Protein-Tyrosine Kinases1201524550.070 Why?
Sensitivity and Specificity12021147260.070 Why?
Animals820231687880.070 Why?
Genome, Human2201544200.060 Why?
Healthcare Disparities1201931580.060 Why?
Octamer Transcription Factors12023230.060 Why?
Cell Transformation, Neoplastic1201429420.060 Why?
Biopsy1201567570.060 Why?
Lactates120234320.050 Why?
Health Services Accessibility1201951380.050 Why?
Cell Proliferation22016104800.050 Why?
Neoplasm Recurrence, Local2201792300.050 Why?
Genetic Testing1201434430.050 Why?
Chemokines120249690.040 Why?
Treatment Outcome32020631190.040 Why?
Epigenomics120239030.040 Why?
Genomics1201457220.040 Why?
Adenocarcinoma1201563520.040 Why?
Basic Helix-Loop-Helix Transcription Factors1202311140.040 Why?
Pneumonectomy1202310940.030 Why?
Heart Failure12019109050.030 Why?
Melanoma1201454750.030 Why?
Chemotherapy, Adjuvant1202334740.030 Why?
Survival Rate22019127810.030 Why?
Mice52023811780.030 Why?
Drug Screening Assays, Antitumor120157310.030 Why?
Aged420191632530.030 Why?
Drug Synergism1201617910.020 Why?
Combined Modality Therapy1202386280.020 Why?
CD8-Positive T-Lymphocytes1202444770.020 Why?
Drug Evaluation, Preclinical1201513720.020 Why?
Benzimidazoles120158510.020 Why?
ras Proteins1201510600.020 Why?
Transfection1201758920.020 Why?
Signal Transduction32017234040.020 Why?
Neoplasm Staging12023110070.020 Why?
Macrophages1202356570.020 Why?
Immunotherapy1202444400.020 Why?
Proto-Oncogene Proteins p21(ras)1201516920.020 Why?
Retrospective Studies32023774260.020 Why?
Inpatients1201925180.020 Why?
Health Status Disparities1201917970.020 Why?
Xenograft Model Antitumor Assays1201635570.020 Why?
Gene Expression Regulation, Neoplastic1202384260.020 Why?
Male420193500270.020 Why?
Boston1201993110.020 Why?
Patient Readmission1201931140.020 Why?
Drug Therapy, Combination1201564850.020 Why?
Lung1202398520.020 Why?
DNA Copy Number Variations1201319400.020 Why?
Transcription Factors12023122070.010 Why?
Aged, 80 and over22019577680.010 Why?
Sequence Analysis, DNA1201348030.010 Why?
Longitudinal Studies12017139900.010 Why?
High-Throughput Nucleotide Sequencing1201335980.010 Why?
Middle Aged320192133670.010 Why?
Female420193801970.010 Why?
Apoptosis1201697280.010 Why?
Prognosis12019290500.010 Why?
Risk Assessment12019233370.010 Why?
Time Factors12019400630.010 Why?
Follow-Up Studies12017390450.010 Why?
Polymorphism, Single Nucleotide12013155250.010 Why?
Prospective Studies12017532800.010 Why?
Risk Factors12019722800.010 Why?
Adult120172140350.000 Why?
Meador's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (115)
Explore
_
Co-Authors (114)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.